- Case report
- Open Access
- Open Peer Review
Hemangiopericytoma in the sacrococcygeal space: a case report
Journal of Medical Case Reportsvolume 4, Article number: 8 (2010)
A hemangiopericytoma is a rare, soft-tissue tumor of vascular origin derived from a pericyte of Zimmerman, which is a modified smooth muscle cell that surrounds the small blood vessels. Hemangiopericytomas can occur wherever there are vascular capillaries. However, there are no previous reports of a hemangiopericytoma in the sacrococcygeal space.
We describe the first reported case of a hemangiopericytoma found in the sacrococcygeal space. A 47-year-old Japanese woman presented with a palpable tumor on the left side of her anus. Preoperative imaging indicated that the tumor was in the sacrococcygeal space without invasion of other organs. A complete resection was performed via a parasacral incision. The histological and immunohistochemical staining patterns supported the diagnosis of a hemangiopericytoma.
A complete resection without piecemeal excision is the best way to treat a hemangiopericytoma. Recognizing the presence of a hemangiopericytoma in the sacrococcygeal space requires appropriate surgery.
A hemangiopericytoma is a rare, soft-tissue tumor of vascular origin derived from a pericyte of Zimmerman, which is a modified smooth muscle cell that surrounds the small blood vessels. This type of tumor was first described by Stout and Murray in 1942 . It represents approximately 5% of all sarcomatous tumors, and can occur anywhere, but more usually in the musculature of the extremities, retroperitoneum, pelvis (uterus, ovary, and urinary bladder), head, neck and lungs . There are no reports of a hemangiopericytoma in the sacrococcygeal space. Since the recommended treatment for a hemangiopericytoma is wide excision, due to high local recurrence [3, 4], it is important to recognize the presence of this malignant tumor in the area surrounding the anus, where various tumors occur. We describe a rare case of a hemangiopericytoma in the sacrococcygeal space.
A 47-year-old Japanese woman presented with a palpable tumor on the left side of her anus. The tumor was elastic and hard and had a smooth surface. She had no pain or tenderness associated with the lesion, and no other clinical symptoms. Computed tomography (CT) scan showed a mass in the sacrococcygeal space with a smooth surface and no invasion to the rectum (Figure 1A). Magnetic resonance imaging (MRI) showed that the outer layer was heterogeneous with high intensity, and that the central layer had an extremely high intensity in T2-weighted images, indicating that the inside of the mass had a rich blood flow (Figure 1B). Rectoscopy revealed that the mucosal surface was intact, and an endoscopic ultrasonography (EUS) demonstrated that the tumor was not derived from the rectum. Fluorodeoxyglucose positron emission tomography (FDG-PET) showed that the maximum standardized uptake value (SUV) at the area was 2.64. The expected SUV is 1.80 to 1.42 in benign soft tissue masses, and 4.20 to 3.16 in malignant soft tissue masses .
The pre-operative images indicated that the tumor was not derived from the rectum. Because of its vascularity, the pre-operative diagnosis was a soft-tissue tumor such as a solitary fibrous tumor, fibrous histiocytoma, synovial sarcoma, mesenchymal chondrosarcoma, or hemangiosarcoma. A biopsy was avoided due to the risk of needle track seeding. The patient underwent a tumorectomy via parasacral incision, without a rectectomy, because pre-operative examinations including a CT and EUS revealed that the rectum was intact. The tumor was completely removed (Figure 2A). The excised tumor was 80 × 75 × 65 mm in diameter with a capsule. Its cut surface was mostly grayish-white and partially reddish (Figure 2B). Histopathological features of the hematoxylin and eosin staining revealed that the tumor contained spindle-shaped cells surrounding the endothelial-lined vascular spaces, which is consistent with the histology of hemangiopericytoma (Figure 3A). Argyrophil fibers were seen on silver impregnation surrounding the tumor cells.
We performed an immunohistological analysis to obtain a diagnosis of the type of mesenchymal tumor. The mesenchymal tumor cells in our patient stained positive for CD34 (Figure 3B) and vimentin, and negative for Bcl-2 (Figure 3C), CD99, c-kit, factor VIII, desmin, alpha-smooth muscle actin, S-100 protein, epithelial membrane antigen, and keratin. The mitotic rate was 1 per 10 high-power fields. No necrotic lesion was observed in our patient's tumor. The tumor was pathologically diagnosed as a hemangiopericytoma.
Little has been published about hemangiopericytoma, a rare, soft-tissue tumor. It can occur anywhere vascular capillaries are found. The tumors most commonly occurs in the musculature of the extremities, retroperitoneum, pelvis (uterus, ovary, and urinary bladder), head, neck and lungs [3, 4].
The pathological diagnosis of a hemangiopericytoma, in comparison to other mesenchymal tumors such as solitary fibrous tumors, can be difficult . Bcl-2 and CD99 immunohistochemistry were used to distinguish a hemangiopericytoma from a solitary fibrous tumor because a solitary fibrous tumor is positive for Bcl-2  and CD99 . We diagnosed a hemangiopericytoma following an examination of the structural features of the mass. Spindle-shaped cells surrounding the endothelial-lined vascular spaces were observed by hematoxylin and eosin staining, and the mass was positive for CD34 and vimentin and negative for Bcl-2, CD99, c-kit, factor VIII, desmin, alpha-smooth muscle actin, S-100 protein, epithelial membrane antigen, and keratin upon immunohistochemical analysis. Making a differential diagnosis between a solitary fibrous tumor and a hemangiopericytoma is particularly difficult and controversial , and a novel molecular marker for distinguishing between the two close entities is required.
Radiotherapy and chemotherapy are not generally effective for the treatment of a hemangiopericytoma . Some have advocated the use of adjuvant radiotherapy in response to the locally aggressive nature of hemangiopericytomas but, due to tumor radioresistance, no differences in local disease control were observed between treatment with and without adjuvant radiotherapy . Spitz et al. reported that hemangiopericytomas showed a poor response to chemotherapy. They treated six patients with pre-operative chemotherapy, and only one of them responded to anthracycline-based chemotherapy . Therefore, complete surgical resection is the only effective therapy for hemangiopericytoma.
Spitz et al. also reported that 5-year and 10-year survival rates of patients with a hemangiopericytoma were 71% and 54%, respectively. In addition, they noted that the survival rate differed between a curative and a non-curative resection. The 5-year survival rate in patients treated with curative resection and non-curative resection was 79% and 50%, respectively . These data indicate that a complete resection is necessary to improve patients' survival rates. Since many benign and malignant diseases occur in the area surrounding the anus, recognizing the presence of this malignant tumor in the sacrococcygeal space is important in order for an anorectal surgeon to avoid inappropriate surgery such as piecemeal excision.
This report presented a rare case of a hemangiopericytoma in the sacrococcygeal space. Many diseases are associated with anal lesions, therefore a thorough differential diagnosis and complete resection without piecemeal excision must always be performed in the management of this type of malignant tumor.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
fluorodeoxyglucose positron emission tomography
magnetic resonance imaging
standardized uptake value.
Hart S, Sisely L: Haemangiopericytoma of the presacral space. Br J Surg. 1973, 60: 583-584. 10.1002/bjs.1800600724.
Vennarecci G, Boschetto A, Esposito A, Giovannelli L, Buscaglia F, Corazza V, Santoro R, Mancini P, Lorusso R, Marino M, Ettorre GM: Malignant haemangiopericytoma of the mesorectum. Chir Ital. 2004, 56: 865-868.
Spitz FR, Bouvet M, Pisters PW, Pollock RE, Feig BW: Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol. 1998, 5: 350-355. 10.1007/BF02303499.
Goldman SM, Davidson AJ, Neal J: Retroperitoneal and pelvic hemangiopericytomas: clinical, radiologic, and pathologic correlation. Radiology. 1988, 168: 13-17.
Aoki J, Watanabe H, Shinozaki T, Takagishi K, Tokunaga M, Koyama Y, Sato N, Endo K: FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol. 2003, 32: 133-138. 10.1007/s00256-002-0586-9.
Enzinger FM, Smith BH: Hemangiopericytoma: an analysis of 106 cases. Hum Pathol. 1976, 7: 61-82. 10.1016/S0046-8177(76)80006-8.
Fukunaga M, Naganuma H, Ushigome S, Endo Y, Ishikawa E: Malignant solitary fibrous tumour of the peritoneum. Histopathol. 1996, 28: 463-466. 10.1046/j.1365-2559.1996.297345.x.
Cristi E, Perrone G, Battista C, Benedetti-Panici P, Rabitti C: A rare case of solitary fibrous tumour of the presacral space: morphological and immunohistochemical features. In Vivo. 2005, 19: 777-780.
Gengler C, Guillou L: Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006, 48: 63-74. 10.1111/j.1365-2559.2005.02290.x.
del Rosario ML, Saleh A: Preoperative chemotherapy for congenital hemangiopericytoma and a review of the literature. J Pediatr Hematol Oncol. 1997, 19: 247-250. 10.1097/00043426-199705000-00013.
Jha N, McNeese M, Barkley HT, Kong J: Does radiotherapy have a role in hemangiopericytoma management? Report of 14 new cases and a review of the literature. Int J Radiat Oncol Biol Phys. 1987, 13: 1399-402. 10.1016/0360-3016(87)90236-7.
The authors declare that they have no competing interests.
YK initiated the concept of the case report, performed the literature search, and wrote the manuscript. SY performed the pathological investigations, helped in the literature search, and approved the final write up. KT performed the surgery. TH and KM helped revise the manuscript. TT assisted in the surgery and also helped draft the manuscript. YO and TW helped revise the manuscript. JI helped revise the article. HY contributed to the clinical management of the patient and helped revise the manuscript. All authors read and approved the final manuscript.